Fred Aslan Sells 25,500 Shares of Artiva Biotherapeutics (NASDAQ:ARTV) Stock
MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) CEO Fred Aslan sold 25,500 shares of Artiva Biotherapeutics stock in a transaction dated Friday, October 17th. The stock was sold at an average price of $6.00, for a total transaction of $153,000.00. Following the transaction, the chief executive officer owned 356,721 shares of the company's stock, valued at approximately $2,140,326. The trade was a 6.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
NASDAQ:ARTV
